Prediction of high-performing spleen-targeted lipid nanoparticles using a deep learning model for robust anticancer immunotherapy
Journal of Materials Chemistry B · 2025
DOI: 10.1039/d5tb01217a ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Honglei Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd, Beijing, China. songgengshen@youcareyk.com. Hauptthemen laut MEDLINE: Nanoparticles, Spleen, Deep Learning, Lipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Messenger RNA (mRNA) therapeutics hold significant potential across a wide range of medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd, Beijing, China. songgengshen@youcareyk.com.
Zitieren
APA
Zhang, H., Ma, J., Pan, F., Liu, Y., Zhang, M., Li, Y., Zhang, C., Huang, H., Zhang, W., Xiu, D., Zhang, W., & Song, G. (2025). Prediction of high-performing spleen-targeted lipid nanoparticles using a deep learning model for robust anticancer immunotherapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d5tb01217a
Vancouver
Zhang H, Ma J, Pan F, Liu Y, Zhang M, Li Y, et al. Prediction of high-performing spleen-targeted lipid nanoparticles using a deep learning model for robust anticancer immunotherapy. Journal of Materials Chemistry B. 2025. doi:10.1039/d5tb01217a
BibTeX
@article{Zhang2025,
author = {Zhang, Honglei and Ma, Jingxuan and Pan, Fulu and Liu, Yangjian and Zhang, Man and Li, Yuqing and Zhang, Chao and Huang, Huajie and Zhang, Wannian and Xiu, Donghui and Zhang, Wei and Song, Gengshen},
title = {Prediction of high-performing spleen-targeted lipid nanoparticles using a deep learning model for robust anticancer immunotherapy},
journal = {Journal of Materials Chemistry B},
year = {2025},
doi = {10.1039/d5tb01217a}
}
EUVIMED